Acta Phlebologica最新文献_第8页

Our experience with vein and hemorrhoid surgery 14 months after introducing microwave thermoablation 应用微波热消融治疗静脉痔术后14个月的临床经验

IF 0.3

Acta Phlebologica Pub Date : 2021-07-01 DOI: 10.23736/S1593-232X.21.00483-5

I. Rozsos, G. Vadász, Melinda Gadácsi

引用次数: 0

COVID-19-associated coagulopathy and immuno-thrombosis covid -19相关凝血功能障碍和免疫血栓形成

IF 0.3

Acta Phlebologica Pub Date : 2021-07-01 DOI: 10.23736/s1593-232x.21.00510-5

D. Čelovská, M. Wawruch, V. Štvrtinová

{"title":"COVID-19-associated coagulopathy and immuno-thrombosis","authors":"D. Čelovská, M. Wawruch, V. Štvrtinová","doi":"10.23736/s1593-232x.21.00510-5","DOIUrl":"https://doi.org/10.23736/s1593-232x.21.00510-5","url":null,"abstract":"The global pandemic Coronavirus disease 2019 (COVID-19) is caused by a novel highly virulent beta-coronavirus SARS-CoV-2. The infection SARS-CoV-2 is associated with a broad spectrum of clinical syndromes, ranging from mild upper respiratory infection to life-threatening cardiovascular complications in humans. COVID-19-associated coagulopathy, endotelitis and immune-thrombosis are typical examples that thrombosis and inflammation mutually reinforce each other. Among the basic features of the COVID-19 disease are the endothelial vascular changes affecting the whole vascular system and leading to micro-thrombosis, mainly localized in the pulmonary microcirculation. The anticoagulants are gold stone of the therapy also for its increased anti-inflammatory and endothelial protective activity. Patients with COVID-19 are at increased risk of venous thromboembolism, and therefore pharmacologic prophylaxis with use of low-molecular-weight heparin, or fondaparinux is recommended not only when hospitalized but also after discharge for up to 45 days in patients at high risk for VTE and low risk of bleeding, independently of the patient recovering mobility. For hospitalized COVID-19 patients with proximal deep vein thrombosis or pulmonary embolism, standard initial parenteral anticoagulation with therapeutic weight adjusted doses is suggested. In general, a one-size-fits-all strategy cannot be applied to COVID-19 patients. These patients need an individualized approach carefully balancing thrombotic and hemorrhagic risk. Further research is required to provide better knowledge of the pathogenesis of COVID-19, more precisely targeted treatment and the correct timing of thromboprophylaxis for this vascular disease.","PeriodicalId":41673,"journal":{"name":"Acta Phlebologica","volume":" ","pages":""},"PeriodicalIF":0.3,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43519980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Mechanical lymphatic therapy to maintain the results of treatment for lymphedema 机械淋巴治疗维持淋巴水肿的治疗效果

IF 0.3

Acta Phlebologica Pub Date : 2021-07-01 DOI: 10.23736/S1593-232X.21.00489-6

H. Godoy, A. Godoy, Renata Lopes Pinto, S. Baruffi, J. M. Godoy, M. F. G. Godoy

引用次数: 3

Clinical and neuroimaging signs of cerebral venous thrombosis in patients with hypertensive dyscirculatory encephalopathy 高血压循环障碍性脑病患者脑静脉血栓形成的临床和神经影像学征象

IF 0.3

Acta Phlebologica Pub Date : 2021-07-01 DOI: 10.23736/S1593-232X.21.00484-7

L. Belova, V. Mashin, N. Belova, M. Moiseev, Anastasiya I. Episheva, P. Antignani, A. Scuderi

引用次数: 1

Pulmonary embolic episode after hybrid treatment with endovascular laser ablation combined with polidocanol foam sclerotherapy 血管内激光消融联合聚多卡因醇泡沫硬化治疗后肺栓塞发作